Evaluation of Attitudes About Fertility

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified October 2012 by Grupo de Estudios Clínicos Oncológicos Peruano
Sponsor:
Collaborator:
European Organisation for Research and Treatment of Cancer - EORTC
Information provided by (Responsible Party):
Grupo de Estudios Clínicos Oncológicos Peruano
ClinicalTrials.gov Identifier:
NCT01705561
First received: October 10, 2012
Last updated: October 12, 2012
Last verified: October 2012
  Purpose
  • Assess the attitudes and feelings of premenopausal Latin American women towards the risk of loss their fertility by adjuvant chemotherapy.
  • Correlate the attitudes with other variables including age at diagnosis, already having children, number of children, level of instruction, marital status, frequency of menstrual cycle.

Condition
Breast Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Evaluation of Attitudes of Premenopausal Latin American Patients With Breast Cancer Towards the Risk of Loss Their Fertility by Chemotherapy

Resource links provided by NLM:


Further study details as provided by Grupo de Estudios Clínicos Oncológicos Peruano:

Estimated Enrollment: 450
Study Start Date: December 2012
Estimated Study Completion Date: June 2013
Detailed Description:

Eligibility criteria:

  • Latin American women with evidence of cancer diagnosis at premenopausal status
  • Over 18 years
  • Agree to sign the informed consent
  • No evidence of infertility.
  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

women with diagnosis of breast cancer in pre menopausal status

Criteria

Inclusion Criteria:

  • women with breast cancer diagnosis in premenopausal
  • over 18 years
  • signed informed consent

Exclusion Criteria:

  • Evidence of infertility at diagnosis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01705561

Locations
Peru
Instituto Nacional de Enfermedades Neoplasicas Not yet recruiting
Lima, Peru, 34
Contact: HENRY GOEMZ, DR    +5112016500 ext 2260    hgomez@gecoperu.org   
Principal Investigator: HENRY L GOMEZ, DR         
Oncosalud Not yet recruiting
Lima, Peru, 41
Contact: ALFREDO AGUILAR, MD    +5137900    aac@oncosalud.pe   
Principal Investigator: Alfredo Aguilar, MD         
Sponsors and Collaborators
Grupo de Estudios Clínicos Oncológicos Peruano
European Organisation for Research and Treatment of Cancer - EORTC
Investigators
Principal Investigator: HENRY L GOMEZ, DR Grupo de Estudios Clínicos Oncológicos Peruano
  More Information

No publications provided

Responsible Party: Grupo de Estudios Clínicos Oncológicos Peruano
ClinicalTrials.gov Identifier: NCT01705561     History of Changes
Other Study ID Numbers: GECOPERU 01-2012
Study First Received: October 10, 2012
Last Updated: October 12, 2012
Health Authority: Peru: Instituto Nacional de Salud

Keywords provided by Grupo de Estudios Clínicos Oncológicos Peruano:
fertility
chemotherapy
breast cancer
latin american women
pre menopausal

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on July 31, 2014